(Total Views: 424)
Posted On: 07/02/2021 9:25:40 AM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The patent is interesting. Are the implications that any treatment that requires blocking of CCR5 receptors is subject to royalties to the assignee(s)/beneficiaries of the patent?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)